Core Viewpoint - A securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. for allegedly making materially false and misleading statements regarding its business practices and patient treatment during the Class Period from February 28, 2020, to October 18, 2024 [1][3]. Group 1: Allegations Against Acadia Healthcare - The lawsuit claims that Acadia Healthcare's business model involved holding vulnerable individuals against their will in its facilities, even when not medically necessary [3]. - It is alleged that many patients in Acadia Healthcare facilities were subjected to abuse [3]. - The company is accused of deceiving insurance providers into covering costs for patients who did not require hospitalization [3]. - As a result of these practices, the statements made by Acadia Healthcare regarding its business operations and future prospects were deemed materially false and misleading [3]. Group 2: Legal Process and Investor Information - Investors in Acadia Healthcare have until December 16, 2024, to seek appointment as a lead plaintiff representative in the class action lawsuit [4]. - A lead plaintiff is typically the investor or small group of investors with the largest financial interest in the case and who are representative of the class [4]. - Investors who have suffered significant losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for more information [5].

Core Points - Rosen Law Firm is reminding purchasers of Acadia Healthcare Company, Inc. securities of the December 16, 2024 lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Acadia Healthcare securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the firm [3] Case Details - The lawsuit alleges that Acadia Healthcare made materially false and misleading statements regarding its business practices, including holding vulnerable individuals against their will and subjecting patients to abuse [5] - It is claimed that Acadia Healthcare deceived insurance providers into covering unnecessary stays in its facilities, leading to significant damages for investors when the truth was revealed [5] Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience [4] - The Rosen Law Firm has a history of successful settlements and has recovered hundreds of millions of dollars for investors [4]

Core Viewpoint - A lawsuit has been filed against Acadia Healthcare Company, Inc. and certain senior executives, alleging misrepresentation of financial results related to insurance fraud and improper patient detainment practices [1][2][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until December 16, 2024, to request to lead the case [2]. Group 2: Allegations Against Acadia Healthcare - Acadia is one of the largest for-profit psychiatric hospital chains in the U.S., and the complaint alleges that the company misrepresented its financial results due to practices involving insurance fraud and holding patients against their will [3]. - A New York Times article highlighted that Acadia has been accused of luring patients and detaining them unnecessarily, which led to a stock price drop of $3.72 per share (4.5%) on September 3, 2024 [4]. - Following disclosures of investigations by the U.S. Attorney's Office and the SEC regarding patient admissions and billing practices, Acadia's stock fell by 16%, from $75.66 to $63.28 per share on September 27, 2024 [5]. - An investigation by the Veterans Affairs Department into potential insurance fraud by Acadia resulted in a further 12% decline in stock price, from $59.32 to $52.03 per share on October 18, 2024 [6]. Group 3: Legal Representation - Investors in Acadia Healthcare are encouraged to submit their information for potential legal representation, with no upfront costs as the firm operates on a contingency fee basis [8].

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”) of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without ...

PHILADELPHIA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of purchasers of ACADIA securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”). Investors that suffered losses from ACADIA (NASDAQ: ACHC) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn mor ...

Investors in Acadia Healthcare Company, Inc. (ACHC) need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 20, 2024 $90 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. ...

NEW YORK, Dec. 2, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the "Class Period"), of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.So what: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without paymen ...

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Acadia Healthcare Company, Inc. securities between February 28, 2020, and October 18, 2024, about the December 16, 2024, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Acadia Healthcare securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the firm or visiting their website [3][6] - The deadline to move the Court to serve as lead plaintiff is December 16, 2024, with the lead plaintiff acting on behalf of other class members [3] Group 2: Case Allegations - The lawsuit alleges that Acadia Healthcare made materially false and misleading statements regarding its business practices, including holding vulnerable individuals against their will and subjecting them to abuse [5] - It is claimed that Acadia deceived insurance providers into covering unnecessary stays in its facilities, leading to misleading statements about the company's operations and prospects [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in recovering hundreds of millions for investors [4] - The firm has been recognized for its leadership in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 [4]

NEW YORK, Nov. 30, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...